Oncology
IsoPlexis' precision development and pathway monitoring are advancing targeting in Oncology
OVERVIEW
Discover sources of resistance to Cancer Signaling Pathway therapies by understanding single-cell pathways that translate to therapeutic insights
IsoPlexis detects the key intracellular pathways in tumor cells that can uncover critical and unseen targets in oncology, helping you understand earlier in development the impacts of your therapies, and also mechanisms behind patient resistance in oncology research.
FEATURED PUBLICATION
Featured Webinar
Cancer Resistance Revealed Through the Single Cell Intracellular Proteome, Masked Through Bulk and Genomics
featured webinars & interviews
See how industry leaders and pioneers are revealing the true functional biology to accelerate research and medicine
Understand the Structure and Functions of the p53 Pathway
Arnold Levine, PhD, Professor Emeritus, Simons Center for Systems Biology, Institute for Advanced Study
Learn how Cancer Cell Communication can Infer a Strategy to Inhibit Tumor Cell Migration
Denis Wirtz, PhD, Vice Provost for Research, Chemical &
Biomolecular Engineering, Pathology, Oncology Director,
Johns Hopkins Physical Sciences-Oncology Center
Johns Hopkins University and Johns Hopkins School of Medicine
Learn to reveal cancer resistance through single-cell intracellular proteome
Rui Zheng, PhD, VP of Innovations, IsoPlexis
Publications & News
Publications highlight customer breakthroughs across research and medicine
Publications
Case Studies & Resources
Stay at the cutting edge of science and medicine with case studies, literature and resources
